EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -0.3024
March 31, 2026 -0.3149
December 31, 2025 -0.1641
September 30, 2025 -0.6578
June 30, 2025 -0.3494
March 31, 2025 -0.5016
December 31, 2024 -3.775
September 30, 2024 -0.3185
June 30, 2024 -6.441
March 31, 2024 -10.28
December 31, 2023 -0.28
Date Value
September 30, 2023 -14.15
June 30, 2023 -10.42
March 31, 2023 -12.25
December 31, 2022 1.562
September 30, 2022 0.0294
June 30, 2022 -0.0102
March 31, 2022 -0.011
December 31, 2021 -0.0571
September 30, 2021 -0.2655
June 30, 2021 -0.0085
March 31, 2021 -0.011

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 0.5324
AngioDynamics, Inc. -0.1689
Alphatec Holdings, Inc. -0.1647
AtriCure, Inc. 0.1832
Baxter International, Inc. 0.2432

EPS Diluted (Quarterly) Related Metrics